168 related articles for article (PubMed ID: 27270539)
1. Restoration of Brain Acid Soluble Protein 1 Inhibits Proliferation and Migration of Thyroid Cancer Cells.
Guo RS; Yu Y; Chen J; Chen YY; Shen N; Qiu M
Chin Med J (Engl); 2016 Jun; 129(12):1439-46. PubMed ID: 27270539
[TBL] [Abstract][Full Text] [Related]
2. Albumin-induced apoptosis of tubular cells is modulated by BASP1.
Sanchez-Niño MD; Fernandez-Fernandez B; Perez-Gomez MV; Poveda J; Sanz AB; Cannata-Ortiz P; Ruiz-Ortega M; Egido J; Selgas R; Ortiz A
Cell Death Dis; 2015 Feb; 6(2):e1644. PubMed ID: 25675304
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer.
Chu BF; Qin YY; Zhang SL; Quan ZW; Zhang MD; Bi JW
Chin Med J (Engl); 2016 Jul; 129(13):1544-52. PubMed ID: 27364790
[TBL] [Abstract][Full Text] [Related]
4. The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin.
Hartl M; Puglisi K; Nist A; Raffeiner P; Bister K
Mol Oncol; 2020 Mar; 14(3):625-644. PubMed ID: 31944520
[TBL] [Abstract][Full Text] [Related]
5. BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/
Li L; Meng Q; Li G; Zhao L
Biomed Res Int; 2020; 2020():8628695. PubMed ID: 33426068
[TBL] [Abstract][Full Text] [Related]
6. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
[TBL] [Abstract][Full Text] [Related]
7. Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression.
Lin CC; Huang YK; Cho CF; Lin YS; Lo CC; Kuo TT; Tseng GC; Cheng WC; Chang WC; Hsiao TH; Lai LC; Shih JY; Liu YH; Chao KSC; Hsu JL; Lee PC; Sun X; Hung MC; Sher YP
Theranostics; 2020; 10(24):10925-10939. PubMed ID: 33042262
[No Abstract] [Full Text] [Related]
8. LncRNA BASP1-AS1 interacts with YBX1 to regulate Notch transcription and drives the malignancy of melanoma.
Li Y; Gao Y; Niu X; Tang M; Li J; Song B; Guan X
Cancer Sci; 2021 Nov; 112(11):4526-4542. PubMed ID: 34533860
[TBL] [Abstract][Full Text] [Related]
9. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor 2 suppresses the growth of thyroid cancer cells through by induction of apoptosis.
Yang Y; Zhang C; Li S; Liu J; Qin Y; Ge A
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e48-e56. PubMed ID: 32043798
[TBL] [Abstract][Full Text] [Related]
11. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
[TBL] [Abstract][Full Text] [Related]
13. Numb had anti-tumor effects in prostatic cancer.
Sun J; Wang K; Teng J; Yu Y; Hua R; Zhou H; Zhong D; Fan Y
Biomed Pharmacother; 2017 Aug; 92():108-115. PubMed ID: 28531799
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma.
Li HG; Zhao LH; Zhang ZH; Liu JZ; Ren K; Li SY; Su ZJ
Cell Physiol Biochem; 2017; 43(5):2037-2046. PubMed ID: 29059670
[TBL] [Abstract][Full Text] [Related]
15. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Yang Q; Ji M; Guan H; Shi B; Hou P
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
[TBL] [Abstract][Full Text] [Related]
16. Loss of Reelin suppresses cell survival and mobility in non-Hodgkin lymphoma.
Dou A; Wang Z; Zhang N; Liu J
Oncol Rep; 2017 Jun; 37(6):3572-3580. PubMed ID: 28498462
[TBL] [Abstract][Full Text] [Related]
17. IL-24 inhibits endometrial cancer cell proliferation by promoting apoptosis through the mitochondrial intrinsic signaling pathway.
Liao S; Yang Y; Chen S; Bi Y; Huang Q; Wei Z; Qin A; Liu B
Biomed Pharmacother; 2020 Apr; 124():109831. PubMed ID: 31972354
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2.
Liang W; Guan H; He X; Ke W; Xu L; Liu L; Xiao H; Li Y
Oncotarget; 2015 Oct; 6(31):31780-91. PubMed ID: 26378658
[TBL] [Abstract][Full Text] [Related]
19. Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation.
Green LM; Wagner KJ; Campbell HA; Addison K; Roberts SG
Nucleic Acids Res; 2009 Feb; 37(2):431-40. PubMed ID: 19050011
[TBL] [Abstract][Full Text] [Related]
20. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
